Questionable History of the Bard IVC Filter
Bard G2 IVC Filters have been linked to countless health complications. The cage-like device, meant to prevent pulmonary embolism, is implanted into the interior vena cava and is meant to stop the migration of blood clots into the lungs, according to the website of Habush Habush Rottier. However, the history behind the device and the company, C.R. Bard, has been littered with controversy and 921 FDA reports of complications linked to the device.
C.R. Bard released an earlier filter model known as the Recovery IVC Filter in 2003. However, as reports of fracture and migration of the device began to surface, C.R. Bard replaced the device with the Bard G2 IVC Filter. The company claimed the device had less of a risk of migrating and fracturing into other parts of the body, but still reports of the same deadly health complications began to occur. Many accused Bard of knowing of the risks and failing to properly warn patients or recall the product. It is suspected that as early as 2003, Bard’s own tests showed the deadly risks of their device. Although there are numerous accounts of C.R. Bard being aware of the dangers of their devices, no action was taken.
When the devices become fractured or lodged into other major organs in the body, individuals can experience deadly complications such as perforation of the lungs or strokes. Patients may seek to have the device removed, but many times surgically removing the filter and its parts from a patient can be too risky for a doctor to perform, leaving a victim with these life-threatening problems. Even after these risks became apparent, the Bard Company continued to market the device to doctors and hospitals. Now, as lawsuits continue to pile up against the company, it is clear that the Bard G2 IVC Filter has proven devastating for many individuals implanted with the device.